PharmaEssentia, a global biopharmaceutical company, reaffirms its enduring commitment to creating robust and reliable access to critical interferon therapies. Amidst growing global concerns about drug shortages of other therapies, PharmaEssentia’s established cGMP manufacturing network and patient-focused approach enable it to help meet the needs of healthcare providers and their patients during this period.
“We recognize that dependable medication supply is essential, and we are working closely with our partners around the world to ensure the continuity of these important therapies. We have made substantial investment to ensure that all of our supply chain elements are strong, of the highest quality, and reliable.”
HealthTech Insights: Octal Integrates Artificial Intelligence to Enhance Healthcare App Innovation
“Our longstanding commitment to operational resilience has positioned us to navigate these challenges effectively,” said Dr. Ko Chung Lin, CEO of PharmaEssentia. “We recognize that dependable medication supply is essential, and we are working closely with our partners around the world to ensure the continuity of these important therapies. We have made substantial investment to ensure that all of our supply chain elements are strong, of the highest quality, and reliable.”
HealthTech Insights: XpertDox and Nao Medical Announce Partnership to Transform Revenue Cycle and Improve Clinical Documentation
Key Factors Supporting PharmaEssentia’s Reliability:
- Robust Supply Chain Infrastructure:
PharmaEssentia has invested in a network designed to maintain strong and steady production and distribution. This approach helps ensure consistent availability, even amidst global shortages and fluctuations of drug supplies. - Comprehensive Support for Patients and Providers:
Beyond robust product availability, PharmaEssentia makes resources available to healthcare professionals and patients globally where permitted. These tools are intended to help with patient education, contributing to better overall care by healthcare professionals for appropriate patients. - Focus on Quality and Operational Rigor:
PharmaEssentia adheres to stringent quality standards to ensure reliable supply of therapies, to meet regulatory and industry benchmarks and to deliver on our commitment to patients and healthcare professionals.
HealthTech Insights: Viper Partners Redefines Real Estate Opportunities for Physicians Nationwide
“Our priority, as always, remains ensuring that patients receive their prescribed therapy without delays,” added Dr. Lin. “We appreciate the trust placed in us by healthcare professionals and patients and will continue working diligently to uphold it.”
To participate in our interviews, please write to our HealthTech Media Room at news@intentamplify.com
Source – businesswire
